cross-tapering can usually be undertaken cautiously over 2 to 4 weeks, the speed is determined by individual tolerability
is limited experience with this switch so extra caution is required. Although interactions are not expected, agomelatine is not expected to mitigate discontinuation reactions from stopping the SNRI
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.